Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | CAM-H2 |
| Trade Name | |
| Synonyms | CAMH2|CAM H2 |
| Drug Descriptions |
CAM-H2 is a targeted radionuclide therapy consisting of a single domain antibody targeting Erbb2 conjugated to radioactive iodine I-131, which may inhibit tumor growth (Annals of Oncology (2019) 30 (suppl_3): iii47-iii64. 10.1093/annonc/mdz100, J. Clin. Oncol. 2018;36:e13017. doi: 10.1200/JCO.2018.36.15_suppl.e13017). |
| DrugClasses | HER2 (ERBB2) Antibody 79 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| CAM-H2 | CAM-H2 | 0 | 1 |